WALTHAM, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced that Ron Zwanziger, Chairman, Chief Executive Officer and President, and Jon Russell, Vice President, Finance, are scheduled to attend the UBS Global Life Sciences Conference being held September 22-25, 2008 at the Grand Hyatt New York in New York City. The Company's presentation is scheduled for 1:00 p.m. on Monday, September 22, 2008 and will be made available to the public through an audio webcast accessible at http://www.ibb.ubs.com . A replay of the webcast will be available via the link above for 30 days. During its presentation, Inverness may discuss and answer questions concerning business and financial developments and trends. Responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com .
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
|SOURCE Inverness Medical Innovations, Inc.|
Copyright©2008 PR Newswire.
All rights reserved